SINONASAL NEUROENDOCRINE CARCINOMA

Clinical trials for SINONASAL NEUROENDOCRINE CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new SINONASAL NEUROENDOCRINE CARCINOMA trials appear

Sign up with your email to follow new studies for SINONASAL NEUROENDOCRINE CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New radiation drug targets Hard-to-Treat cancers in early trial

Disease control Recruiting now

This early-phase trial tests a new drug that delivers radiation directly to cancer cells with a specific protein (somatostatin receptor). It is for adults with advanced lung, kidney, head and neck, digestive tract, or adrenal gland tumors that cannot be removed by surgery. The go…

Matched conditions: SINONASAL NEUROENDOCRINE CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 16, 2026 22:36 UTC

SINONASAL NEUROENDOCRINE CARCINOMA

Get alerted when new SINONASAL NEUROENDOCRINE CARCINOMA trials appear

New radiation drug targets Hard-to-Treat cancers in early trial